Autolus Therapeutics Sees FY2026 Sales $120.000M-$135.000M vs $130.062M Est
Benzinga Newsdesk 5 months ago
NewsGuidance
Autolus Therapeutics (NASDAQ:AUTL) sees FY2026 sales of $120.000 million-$135.000 million vs $130.062 million analyst estimate.
Autolus Therapeutics (NASDAQ:AUTL) sees FY2026 sales of $120.000 million-$135.000 million vs $130.062 million analyst estimate.